John Day

18.9k citations
316 papers · 17.1k · 5 hit papers · h-index 69

Impact in

  • Genetics top 0.1%
    • Neurogenetic and Muscular Disorders Research
    • Virus-based gene therapy research
    • Genomics and Rare Diseases
    • Genetic Neurodegenerative Diseases
    • Hereditary Neurological Disorders

Papers in

John Day

301 papers receiving 16.3k citations

John Day's Hit Papers

Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial 2021 · 380 citations
3800+8+16Years since publication2505007501k

Peers

John Day
Comparison fields: 5 of 159
  • Genetics 5.1k
  • Cellular and Molecular Neuroscience 5k
  • Molecular Biology 5k
  • Neurology 750
  • Genetics 1.1k
Replace Haluk Topaloğlu with:
Haluk Topaloğlu Türkiye
Basil T. Darras United States
Richard T. Moxley United States
Kevin M. Flanigan United States
Klaus Zerres Germany
Janbernd Kirschner Germany
Kathryn J. Swoboda United States
Kayoko Saito Japan
Kate M. D. Bushby United Kingdom
Perry B. Shieh United States
John Day relative to Haluk Topaloğlu Türkiye Haluk Topaloğlu's profile →
Citations per field
00.5×2×2.8×
Haluk Topaloğlu · 1×
Citations per year

Countries citing papers authored by John Day

Since Specialization
Citations

This map shows the geographic impact of John Day's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Day with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Day more than expected).

Fields of papers citing papers by John Day

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Day. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Day. The network helps show where John Day may publish in the future.

Co-authors

The 25 scholars most cited alongside John Day, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John Day Line = papers co-authored together John Day links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 316 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy
Hit paper breakdown →
20181125
2
Myotonic Dystrophy Type 2 Caused by a CCTG Expansion in Intron 1 of ZNF9
Hit paper breakdown →
20011033
3
Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study
Hit paper breakdown →
2016834
4 2002548
5 1999529
6
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial
Hit paper breakdown →
2021380
7 2017377
8 2006363
9 2003358
10 2014343
11
Risdiplam in Type 1 Spinal Muscular Atrophy
Hit paper breakdown →
2021330
12 2006305
13 2014292
14 2009270
15 2016249
16 2011237
17 1998210
18 2012200
19 2018178
20 2004174

About John Day

John Day is a scholar working on Genetics, Cellular and Molecular Neuroscience, Molecular Biology, Physiology and Neurology, having authored 316 papers that have together received 17.1k indexed citations. Recurring topics across this work include Neurogenetic and Muscular Disorders Research (136 papers), Genetic Neurodegenerative Diseases (66 papers), Muscle Physiology and Disorders (60 papers), Hereditary Neurological Disorders (22 papers), Lysosomal Storage Disorders Research (12 papers), Historical Economic and Social Studies (10 papers), Nicotinic Acetylcholine Receptors Study (6 papers) and Medieval History and Crusades (5 papers). The work is most often cited by research in Genetics (5.1k citations), Cellular and Molecular Neuroscience (5k citations), Molecular Biology (5k citations), Neurology (750 citations) and Genetics (1.1k citations). John Day has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Laura P.W. Ranum, Melinda L. Moseley, K. Ricker, Joline C. Dalton, Kellie A. Benzow, Christina L. Liquori, Richard S. Finkel, Michael D. Koob, Wolfram Kreß and Susan L. Naylor. Their work appears in journals such as Neurology, Neuromuscular Disorders, Journal of Neuromuscular Diseases, Muscle & Nerve and Annals of Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact